                         SEQUENCE LISTING

<110>  GALDERMA RESEARCH & DEVELOPMENT
 
<120>  Modulateurs de la UDP-glucose cramide glucosyltransfrase dans 
       le traitement de l'acn ou de l'hyperkratinisation

<130>  OA06272/CBE

<150>  FR0653030
<151>  2006-07-19

<160>  1     

<170>  PatentIn version 3.3

<210>  1
<211>  1637
<212>  DNA
<213>  Homo sapiens

<400>  1
gaggcgaacc ggagcgcggg gccgcggtcg ccccgaccag agccgggaga ccgcagcacc     60

cgcagccgcc cgcgagcgcg ccgaagacag cgcgcaggcg agagcgcgcg ggcgggggcg    120

cgcaggccct gcccgcccct tccgtcccca cccccctccg ccctttcctc tccccacctt    180

cctctcgcct cccgcgcccc cgcaccgggc gcccaccctg tcctcctcct gcgggagcgt    240

tgtccgtgtt ggcggccgca gcgggccggg ccggtccggc gggccggggg atggcgctgc    300

tggacctggc cttggaggga atggccgtct tcgggttcgt cctcttcttg gtgctgtggc    360

tgatgcattt catggctatc atctacaccc gattacacct caacaagaag gcaactgaca    420

aacagcctta tagcaagctc ccaggtgtct ctcttctgaa accactgaaa ggggtagatc    480

ctaacttaat caacaacctg gaaacattct ttgaattgga ttatcccaaa tatgaagtgc    540

tcctttgtgt acaagatcat gatgatccag ccattgatgt atgtaagaag cttcttggaa    600

aatatccaaa tgttgatgct agattgttta taggtggtaa aaaagttggc attaatccta    660

aaattaataa tttaatgcca ggatatgaag ttgcaaagta tgatcttata tggatttgtg    720

atagtggaat aagagtaatt ccagatacgc ttactgacat ggtgaatcaa atgacagaaa    780

aagtaggctt ggttcacggg ctgccttacg tagcagacag acagggcttt gctgccacct    840

tagagcaggt atattttgga acttcacatc caagatacta tatctctgcc aatgtaactg    900

gtttcaaatg tgtgacagga atgtcttgtt taatgagaaa agatgtgttg gatcaagcag    960

gaggacttat agcttttgct cagtacattg ccgaagatta ctttatggcc aaagcgatag   1020

ctgaccgagg ttggaggttt gcaatgtcca ctcaagttgc aatgcaaaac tctggctcat   1080

attcaatttc tcagtttcaa tccagaatga tcaggtggac caaactacga attaacatgc   1140

ttcctgctac aataatttgt gagccaattt cagaatgctt tgttgccagt ttaattattg   1200

gatgggcagc ccaccatgtg ttcagatggg atattatggt atttttcatg tgtcattgcc   1260

tggcatggtt tatatttgac tacattcaac tcaggggtgt ccagggtggc acactgtgtt   1320

tttcaaaact tgattatgca gtcgcctggt tcatccgcga atccatgaca atatacattt   1380

ttttgtctgc attatgggac ccaactataa gctggagaac tggtcgctac agattacgct   1440

gtgggggtac agcagaggaa atcctagatg tataactaca gctttgtgac tgtatataaa   1500

ggaaaaaaga gaagtattat aaattatgtt tatataaatg cttttaaaaa tctaccttct   1560

gtagttttat cacatgtatg ttttggtatc tgttctttaa tttatttttg catggcactt   1620

gcatctgtga aaaaaaa                                                  1637


